Cover Image
市場調查報告書

流式細胞技術的全球市場分析

Analysis of the Global Flow Cytometry Market

出版商 Frost & Sullivan 商品編碼 335412
出版日期 內容資訊 英文 187 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
流式細胞技術的全球市場分析 Analysis of the Global Flow Cytometry Market
出版日期: 2015年07月17日 內容資訊: 英文 187 Pages
簡介

流式細胞技術在免疫和細胞增生、癌症、幹細胞等研究用途廣泛利用,不過,由於近幾年被低開發地區的HIV患者的CD4細胞標記的定量化的需求增加,在臨床用途中進行積極聯盟。卡式的下一代流式細胞技術的利用在臨床市場中擴大。

本報告提供全球流式細胞技術的市場相關調查、各用途 (臨床/研究)、產品區分 (設備/試劑)、地區以及各國的收益預測、影響市場成長因素分析、技術趨勢、競爭環境與市場佔有率、策略性建議等彙整資料。

第1章 摘要整理

  • 主要調查結果
  • CEO的展望
  • 關注的企業 (設備)
  • 關注的企業 (試劑)
  • 關注的企業 (軟體)
  • 3大預測等

第2章 市場概要

  • 市場背景
  • 對研究領域的技術引進
  • 對臨床領域的技術引進
  • 市場區隔
  • 全球市場的展望

第3章 競爭策略

  • 競爭因素
  • 新的市場機會
  • M&A、聯盟的評估
  • 已上市產品分析

第4章 市場促進因素、阻礙要素、趨勢:市場整體

  • 市場促進因素
  • 市場成長的阻礙要素
  • 7大趨勢的對市場的影響

第5章 預測、趨勢:市場整體

  • 檢測
  • 前提條件、定義
  • 收益預測
  • 收益預測:各用途
  • 收益預測:各技術
  • 收益預測相關討論
  • 收益佔有率的預測:各地區
  • 收益預測:各地區

第6章 需求分析:市場整體

  • 流式細胞技術品牌認知度
  • 主要的研究用用途:各組織類型
  • 各組織類型的其他的研究用用途
  • 主要的臨床用用途
  • 其他臨床用用途
  • 普及分析:只有美國

第7章 競爭環境

  • 終端用戶及市場
  • 產品分析、主要經營者、軟體的兼容性:概要
  • 全球市場佔有率
  • 市場佔有率分析
  • 其他的企業的清單
  • 主要經營者

第8章 美國市場分析

  • 市場分析
  • PEST分析
  • 主要調查結果
  • 標準
  • 收益預測
  • 收益預測:各用途
  • 收益預測:各技術
  • 研究用試劑 vs. 臨床用試劑
  • 收益預測相關討論
  • 市場佔有率分析

第9章 檢查數量分析

第10章 歐洲市場分析

  • 市場分析
  • PEST分析
  • 主要調查結果
  • 標準
  • 收益預測
  • 收益明細:各國
  • 收益預測:各用途
  • 收益預測:各技術
  • 研究用試劑 vs. 臨床用試劑
  • 收益預測相關討論
  • 市場佔有率分析

第11章 歐洲的流式細胞技術實驗室的認證

  • 核准流程
  • 歐洲臨床細胞測量檢驗的清單

第12章 亞太地區、其他地區的分析

  • 市場分析
  • PEST分析
  • 主要調查結果
  • 標準
  • 收益預測
  • 收益預測:各用途
  • 收益預測:各技術
  • 研究用試劑 vs. 臨床用試劑
  • 中國的流式細胞技術市場
  • 印度的流式細胞技術市場:概要

第13章 總論

  • 3大預測
  • 考察
  • 免責聲明

第14章 附錄

目錄
Product Code: NF0E-01-00-00-00

Cartridge-based Next Generation Flow Cytometry Instruments Broaden Applications in Clinical Market

Globally, flow cytometry remains a popular tool for research applications including immuno-phenotyping, cell proliferation, cancer, and stem cells. But the market is witnessing active partnerships in clinical applications primarily because of demand from underdeveloped nations to quantitate CD4 cell markers in HIV patients. In this research, the total market includes revenues estimated by research and clinical applications; and instruments and reagents for the US, Europe, and Asia-Pacific/Rest of World. The study period is 2012-2018 with a 2014 base year and a 2015-2018 forecast period. Study highlights include market drivers and restraints, US test volume estimates, technology trends, competitive analysis, and strategic recommendations.

Table of Contents

1. EXECUTIVE SUMMARY

Executive Summary

  • 1. Key Findings
  • 2. Key Findings (continued)
  • 3. Scope and Segmentation
  • 4. Market Segmentation
  • 5. Key Questions This Study Will Answer
  • 6. Measurements
  • 7. Measurements (continued)
  • 8. CEO's Perspective
  • 9. Key Companies to Watch (Instruments)
  • 10. Key Companies to Watch (Instruments) (continued)
  • 11. Key Companies to Watch (Reagents)
  • 12. Key Companies to Watch (Software)
  • 13. Executive Summary-3 Big Predictions

2. MARKET OVERVIEW

Market Overview

  • 1. Market Background
  • 2. Research Applications Technology Adoption
  • 3. Clinical Applications Technology Adoption
  • 4. Market Segmentation
  • 5. Global Market Perspective
  • 6. Global Market Perspective (continued)

3. COMPETITIVE PLAYBOOK

Competitive Playbook

  • 1. Competitive Factors
  • 2. New Market Opportunities
  • 3. New Market Opportunities (continued)
  • 4. New Market Opportunities (continued)
  • 5. Merger, Acquisition, and Partnership Assessment
  • 6. Merger, Acquisition, and Partnership Assessment (continued)
  • 7. Merger, Acquisition, and Partnership Assessment (continued)
  • 8. Merger, Acquisition, and Partnership Assessment (continued)
  • 9. Merger, Acquisition, and Partnership Assessment (continued)
  • 10. Marketed Product Analysis
  • 11. Marketed Product Analysis (continued)
  • 12. Marketed Product Analysis (continued)
  • 13. Marketed Product Analysis (continued)
  • 14. Marketed Product Analysis (continued)
  • 15. Marketed Product Analysis (continued)
  • 16. Marketed Product Analysis (continued)
  • 17. Marketed Product Analysis (continued)
  • 18. Marketed Product Analysis (continued)

4. DRIVERS, RESTRAINTS, AND TRENDS-TOTAL FLOW CYTOMETRY MARKET

Drivers, Restraints, and Trends-Total Flow Cytometry Market

  • 1. Market Drivers
  • 2. Market Restraints
  • 3. Market Impact of Top 7 Trends

5. FORECASTS AND TRENDS-TOTAL FLOW CYTOMETRY MARKET

Forecasts and Trends-Total Flow Cytometry Market

  • 1. Measurements
  • 2. Measurements (continued)
  • 3. Forecast Assumptions and Definitions
  • 4. Revenue Forecast
  • 5. Revenue Forecast by Application
  • 6. Revenue Forecast by Technology
  • 7. Revenue Forecast Discussion
  • 8. Revenue Forecast Discussion (continued)
  • 9. Revenue Forecast Discussion (continued)
  • 10. Percent Revenue Forecast by Region
  • 11. Revenue Forecast by Region

6. DEMAND ANALYSIS-TOTAL FLOW CYTOMETRY MARKET

Demand Analysis-Total Flow Cytometry Market

  • 1. Overall Brand Awareness of Flow Cytometry
  • 2. Predominantly Used Research Applications by Organization Type
  • 3. Other Research Applications by Organization Type-Verbatim Responses
  • 4. Predominantly Used Clinical Applications
  • 5. Other Clinical Applications-Verbatim Responses
  • 6. Penetration Analysis-US Only

7. COMPETITIVE ENVIRONMENT

Competitive Environment

  • 1. End Users and Markets Served by Research and Clinical Flow Cytometry
  • 2. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility
  • 3. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility (continued)
  • 4. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility (continued)
  • 5. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility (continued)
  • 6. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility (continued)
  • 7. Overview-Flow Cytometer Product Analysis, Top Competitors Loader and Software Compatibility (continued)
  • 8. Global Flow Cytometry Market Share
  • 9. Market Share Analysis
  • 10. List of “Other” Companies
  • 11. List of “Other” Companies (continued)
  • 12. Top Competitors
  • 13. Top Competitors (continued)

8. US ANALYSIS

US Analysis

  • 1. US Market Analysis
  • 2. US PEST Analysis
  • 3. Key Findings
  • 4. Metrics
  • 5. Revenue Forecast
  • 6. Revenue Forecast by Application
  • 7. Revenue Forecast by Technology
  • 8. Research Reagents vs. Clinical Reagents
  • 9. Revenue Forecast Discussion
  • 10. Revenue Forecast Discussion (continued)
  • 11. Revenue Forecast Discussion (continued)
  • 12. Revenue Forecast Discussion (continued)
  • 13. Revenue Forecast Discussion (continued)
  • 14. Market Share Analysis

9. TEST VOLUME ANALYSIS

Test Volume Analysis

  • 1. Frost & Sullivan Analysis of Test Volume by Procedure
  • 2. 88182-Cell Marker Study
  • 3. 88182-Cell Marker Study (continued)
  • 4. 88184-Flowcytometry/tc 1 Marker
  • 5. 88184-Flowcytometry/tc 1 Marker (continued)
  • 6. 88185-Flowcytometry/tc add-on
  • 7. 88185-Flowcytometry/tc add-on (continued)
  • 8. 88187-Flowcytometry/read 2-8
  • 9. 88187-Flowcytometry/read 2-8 (continued)
  • 10. 88188-Flowcytometry/read 9-15
  • 11. 88188-Flowcytometry/read 9-15 (continued)
  • 12. 88189-Flowcytometry/read 16 and above
  • 13. 88189-Flowcytometry/read 16 and above (continued)
  • 14. 86355-B Cell Count
  • 15. 86355-B Cell Count (continued)
  • 16. 86356-Mononuclear Cell Antigen
  • 17. 86356-Mononuclear Cell Antigen (continued)
  • 18. 86357-Natural Killer (Nk) Cells Total Count
  • 19. 86357-Natural Killer (Nk) Cells Total Count (continued)
  • 20. 86359-T Cells Total Count
  • 21. 86359-T Cells Total Count (continued)
  • 22. 86360-T Cells Absolute CD4 and CD8 Count/Ratio
  • 23. 86360-T Cells Absolute CD4 and CD8 Count/Ratio (continued)
  • 24. 86361-T Cells Absolute CD4 Count
  • 25. 86361-T Cells Absolute CD4 Count (continued)
  • 26. 86367-Stem Cells (IE, CD34) Total Count
  • 27. 86367-Stem Cells (IE, CD34) Total Count (continued)

10. EUROPE ANALYSIS

Europe Analysis

  • 1. Europe Market Analysis
  • 2. Europe PEST Analysis
  • 3. Key Findings
  • 4. Metrics
  • 5. Revenue Forecast
  • 6. Revenue Breakdown by Country
  • 7. Revenue Forecast by Application
  • 8. Revenue Forecast by Technology
  • 9. Research Reagents vs. Clinical Reagents
  • 10. Revenue Forecast Discussion
  • 11. Revenue Forecast Discussion (continued)
  • 12. Market Share Analysis

11. ACCREDITATION OF EUROPEAN FLOW CYTOMETRY LABORATORIES

Accreditation of European Flow Cytometry Laboratories

  • 1. Accreditation Process of Clinical Flow Labs in Europe
  • 2. Accreditation Process of Clinical Flow Labs in Europe (continued)
  • 3. Accreditation Process of Clinical Flow Labs in Europe (continued)
  • 4. Accreditation Process of Clinical Flow Labs in Europe (continued)
  • 5. Accreditation Process of Clinical Flow Labs in Europe (continued)
  • 6. Accreditation Process of Clinical Flow Labs in Europe (continued)
  • 7. List of Clinical Cytometric Tests in Europe

12. APAC AND ROW ANALYSIS

APAC and ROW Analysis

  • 1. APAC and ROW Market Analysis
  • 2. APAC and ROW PEST Analysis
  • 3. Key Findings
  • 4. Metrics
  • 5. Revenue Forecast
  • 6. Revenue Forecast by Application
  • 7. Revenue Forecast by Technology
  • 8. Research Reagents vs. Clinical Reagents
  • 9. China's Flow Cytometry Markets
  • 10. India's Flow Cytometry Market Overview

13. THE LAST WORD

The Last Word

  • 1. The Last Word-3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. The Last Word-Discussion (continued)
  • 4. Legal Disclaimer

14. APPENDIX

Appendix

  • 1. Important Market Metrics
  • 2. Drivers Explained
  • 3. Drivers Explained (continued)
  • 4. Drivers Explained (continued)
  • 5. Restraints Explained
  • 6. Restraints Explained (continued)
  • 7. Restraints Explained (continued)
  • 8. Restraints Explained (continued)
  • 9. Overall Systems Included
  • 10. Overall Systems Included (continued)
  • 11. Methodology
  • 12. Additional Studies of Interest
  • 13. Additional Studies of Interest (continued)
  • 14. List of Exhibits
  • 15. List of Exhibits (continued)
  • 16. List of Exhibits (continued)
  • 17. List of Exhibits (continued)
  • 18. List of Exhibits (continued)
  • 19. List of Exhibits (continued)
  • 20. List of Exhibits (continued)
  • 21. List of Exhibits (continued)
  • 22. List of Exhibits (continued)
  • 23. List of Exhibits (continued)
Back to Top